EVOTEC AND APEIRON BIOLOGICS TO DISCOVER NOVEL PAIN THERAPEUTICS
Evotec AG and Apeiron Biologics GmbH today announced that they have entered
into a discovery collaboration to develop small molecules targeting a novel
therapeutic concept for pain relief. This concept is based on research activities
of Prof Josef Penninger, Director of the Institute for Molecular Biotechnology
of the Austrian Academy of Sciences (IMBA).